| Title | Author(s) | Issue date | ???itemlist.??? |
| Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas | Papachristou, D. J.; Batistatou, A.; Sykiotis, G. P.; Varakis, I.; Papavassiliou, A. G. | 24-Nov-2015 | - |
| Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia | Valasoulis, G.; Koliopoulos, G.; Founta, C.; Kyrgiou, M.; Tsoumpou, I.; Valari, O.; Martin-Hirsch, P.; Daponte, A.; Karakitsos, P.; Paraskevaidis, E. | 24-Nov-2015 | - |
| Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1) | Zagorianakou, N.; Ioachim, E.; Mitselou, A.; Kitsou, E.; Zagorianakou, P.; Stefanaki, S.; Makrydimas, G.; Agnantis, N. J. | 24-Nov-2015 | - |
| Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes | Ravazoula, P.; Batistatou, A.; Aletra, C.; Ladopoulos, J.; Kourounis, G.; Tzigounis, B. | 24-Nov-2015 | - |
| Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip | Kyzas, P. A.; Stefanou, D.; Agnantis, N. J. | 24-Nov-2015 | - |
| Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation | Fountzilas, G.; Kourea, H. P.; Bobos, M.; Televantou, D.; Kotoula, V.; Papadimitriou, C.; Papazisis, K. T.; Timotheadou, E.; Efstratiou, I.; Koutras, A.; Pentheroudakis, G.; Christodoulou, C.; Aravantinos, G.; Miliaras, D.; Petraki, K.; Papandreou, C. N.; Papakostas, P.; Bafaloukos, D.; Repana, D.; Razis, E.; Pectasides, D.; Dimopoulos, A. M. | 24-Nov-2015 | - |
| Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers | Marcus, K. J.; Astrakas, L. G.; Zurakowski, D.; Zarifi, M. K.; Mintzopoulos, D.; Poussaint, T. Y.; Anthony, D. C.; De Girolami, U.; Black, P. M.; Tarbell, N. J.; Tzika, A. A. | 24-Nov-2015 | - |
| Prognostic evaluation of metallothionein expression in human colorectal neoplasms | Ioachim, E. E.; Goussia, A. C.; Agnantis, N. J.; Machera, M.; Tsianos, E. V.; Kappas, A. M. | 24-Nov-2015 | - |
| The role of p16(INK4a) immunostaining in the risk assessment of women with LSIL cytology: a prospective pragmatic study | Valasoulis, G.; Tsoumpou, I.; Founta, C.; Kyrgiou, M.; Dalkalitsis, N.; Nasioutziki, M.; Kassanos, D.; Paraskevaidis, E.; Karakitsos, P. | 24-Nov-2015 | - |
| The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development | Ziech, D.; Franco, R.; Georgakilas, A. G.; Georgakila, S.; Malamou-Mitsi, V.; Schoneveld, O.; Pappa, A.; Panayiotidis, M. I. | 24-Nov-2015 | - |
| Targeting VEGF, EGFR, and other interacting pathways for gastric cancer-promises and reality | Liakakos, T.; Fatourou, E.; Ziogas, D.; Lykoudis, E.; Roukos, D. H. | 24-Nov-2015 | - |
